BENEFITING: National Foundation for Cancer Research
EVENT: Cannons Fighting Cancer
EVENT DATE: Jun 23, 2016
I’m joining the Boston Cannons Major League Lacrosse team in the #CannonsFightingCancer initiative. The theme of the event is “Unity”, as in we’re all in this together – the Cannons, NFCR, sponsors, survivors, patients, US Lacrosse, youth lacrosse leagues across New England, Massachusetts General Hospital (MGH), Cannons fans, and the business and research communities in Boston, making a difference in funding cancer research. This year the funds raised will go directly to the laboratory of Dr. Daniel Haber, Director of the MGH Cancer Center.
I’ve been writing about the promise of liquid biopsy in cancer detection and treatment on my blog for several months http://davebjork.blogspot.com/ and specifically about Circulating Tumor Cell (CTC) research being done at MGH, led by Dr. Haber.
The National Foundation for Cancer Research (NFCR) has supported Dr. Haber’s research since 2004. NFCR support had helped lead Dr. Haber’s lab to a strategic relationship with Johnson & Johnson to commercialize his CTC Chip, so I was obviously impressed by his work. Because I have a personal mantra that “It’s about relationships”, it was important for me to meet Dr. Haber to solidify my commitment to raising funds to support his research – and I have met him. So let me tell you that I am equally impressed with Daniel Haber the man. He is a brilliant researcher, passionate about his work, committed to helping save lives, and he is also a really kind, humble, personable man. So I can represent that the funds we will raise to support his work will go to a man that all of us can embrace as sincere and committed to the same cause we all support – early detection and targeted treatment of cancer.
This is a very specific research project reviewed by NFCR's Science Advisory Board. All funds raised here will go directly to the Haber Lab in Charlestown, Massachusetts using the Play4theCure platform that insures that 100% of the funds raised go to research.